Your session is about to expire
← Back to Search
Transcranial Direct Current Stimulation for Tinnitus (MRI HDtES-T Trial)
MRI HDtES-T Trial Summary
This trial is testing how a neurostimulation technique, transcranial electrical stimulation (tES), affects brain function in adults with chronic subjective tinnitus. The specific kind of tES being tested is transcranial direct current stimulation (tDCS), where a mild, constant current is passed between electrodes placed on the scalp.
- Tinnitus
MRI HDtES-T Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 2 & 3 trial • 160 Patients • NCT02483468MRI HDtES-T Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this research endeavor limited to those under 25 years of age, or are the requirements more expansive?
"To qualify for this clinical trial, the patient must be aged 18 to 75. There are additional trials available for those under 18 and over 65 years old; 2 studies and 39 respectively."
Who meets the criteria for participation in this experiment?
"This clinical trial will accept 20 individuals with tinnitus, aged between 18 and 75. In order to qualify for this study, participants must have the ability to provide informed consent, have discussed their symptoms of tinnitus with a qualified medical professional (such as an audiologist or physician) to confirm that the condition is not caused by any physical/neurological issues; been living with their current symptomatology for at least one year prior to start date; present in at least 50% of awake time while intruding 10% of awake time when attempting masking/ignoring it; and should be on a stable medication regimen"
Are there any vacant slots that participants can join this clinical trial?
"Data on clinicaltrials.gov reveals that this trial, which was first published on January 1st 2022 and last revised June 6th 2022 is no longer recruiting patients. However, 45 other trials are currently looking for candidates to join their studies."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
How responsive is this trial?
Average response time
- < 2 Days
Most responsive sites:
- Center for Translational Imaging at Northwestern University: < 24 hours
Typically responds via
Share this study with friends
Copy Link
Messenger